BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31391602)

  • 1. Deslorelin and naltrexone stimulate follicular development in mares during autumn transition and early anestrus.
    ; Kwong GPS; Klein C
    Can Vet J; 2019 Aug; 60(8):855-858. PubMed ID: 31391602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of deslorelin or hCG administration on reproductive performance in first postpartum estrus mares.
    Blanchar TL; Brinsko SP; Rigby SL
    Theriogenology; 2002 Jul; 58(1):165-9. PubMed ID: 12182359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the GnRH analogue, deslorelin acetate, in a slow-release implant to accelerate ovulation in oestrous mares.
    Meyers PJ; Bowman T; Blodgett G; Conboy HS; Gimenez T; Reid MP; Taylor BC; Thayer J; Jöchle W; Trigg TE
    Vet Rec; 1997 Mar; 140(10):249-52. PubMed ID: 9080642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration and timing of fertile ovulation in cyclic mares with a deslorelin implant.
    Gånheim A; Gånheim A; Jöchle W
    Acta Vet Scand; 1995; 36(4):393-400. PubMed ID: 8669367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of eFSH and deslorelin treatment regimes on ovarian stimulation and embryo production of donor mares in early vernal transition.
    Raz T; Carley S; Card C
    Theriogenology; 2009 Jun; 71(9):1358-66. PubMed ID: 19329174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulatory response to GnRH agonist during early and late fall in mares.
    Spencer KM; Podico G; Megahed AA; Jones KL; Bittar JHJ; Canisso IF
    Theriogenology; 2022 Jun; 185():140-148. PubMed ID: 35405532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deslorelin acetate on gonadotropin secretion and ovarian follicle development in cycling mares.
    Farquhar VJ; McCue PM; Nett TM; Squires EL
    J Am Vet Med Assoc; 2001 Mar; 218(5):749-52. PubMed ID: 11280410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of double ovulation in mares using deslorelin acetate.
    Nagao JF; Neves Neto JR; Papa FO; Alvarenga MA; Freitas-Dell'Aqua CP; Dell'Aqua JA
    Anim Reprod Sci; 2012 Dec; 136(1-2):69-73. PubMed ID: 23182475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new injectable short-term release deslorelin in foal-heat mares.
    Stich KL; Wendt KM; Blanchard TL; Brinsko SP
    Theriogenology; 2004 Sep; 62(5):831-6. PubMed ID: 15251234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares.
    McCue PM; Farquhar VJ; Carnevale EM; Squires EL
    Theriogenology; 2002 Sep; 58(5):865-70. PubMed ID: 12212887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Clinical Treatment with Phenylbutazone and Meloxicam in the Pre-ovulatory Period Influence the Ovulation Rate in Mares?
    Lima AG; Costa LC; Alvarenga MA; Martins CB
    Reprod Domest Anim; 2015 Oct; 50(5):771-5. PubMed ID: 26280558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary responsiveness to GnRH in mares following deslorelin acetate implantation to hasten ovulation.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2002 Oct; 80(10):2681-7. PubMed ID: 12413091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.
    Glazar BS; McCue PM; Bruemmer JE; Squires EL
    Theriogenology; 2004 Jul; 62(1-2):57-64. PubMed ID: 15159101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen.
    Hemberg E; Lundeheim N; Einarsson S
    Reprod Domest Anim; 2006 Dec; 41(6):535-7. PubMed ID: 17107513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superovulation, embryo recovery, and pregnancy rates from seasonally anovulatory donor mares treated with recombinant equine FSH (reFSH).
    Roser JF; Etcharren MV; Miragaya MH; Mutto A; Colgin M; Losinno L; Ross PJ
    Theriogenology; 2020 Jan; 142():291-295. PubMed ID: 31711702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the time of ovulation in the mare with a short-term implant releasing the GnRH analogue deslorelin.
    Meinert C; Silva JF; Kroetz I; Klug E; Trigg TE; Hoppen HO; Jöchle W
    Equine Vet J; 1993 Jan; 25(1):65-8. PubMed ID: 8422889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of BioRelease Deslorelin® injection for induction of ovulation in oestrus mares: a field study.
    Finan SA; Lamkin EL; McKinnon AO
    Aust Vet J; 2016 Sep; 94(9):338-40. PubMed ID: 27569838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation, pregnancy rate and early embryonic development in vernal transitional mares treated with equine- or porcine-FSH.
    Raz T; Amorim MD; Stover BC; Card CE
    Reprod Domest Anim; 2010 Apr; 45(2):287-94. PubMed ID: 19144034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ovulation in seasonally anestrous mares under ambient lights using recombinant equine FSH (reFSH).
    Meyers-Brown GA; McCue PM; Troedsson MH; Klein C; Zent W; Ferris RA; Lindholm AR; Scofield DB; Claes AN; Morganti M; Colgin MA; Wetzel RL; Peters AR; Roser JF
    Theriogenology; 2013 Sep; 80(5):456-62. PubMed ID: 23768752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.